Anúncio
Anúncio

NEO

NEO logo

NeoGenomics, Inc.

12.95
USD
Patrocinado
+0.12
+0.90%
09 de jan., 13:24 UTC -5
Abrir

Relatórios de Lucros NEO

Rácio de surpresa positiva

NEO separação 35 de 40 últimas estimativas.

88%

Próximo Relatório

Data do Próximo Relatório
16 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$190.14M
/
$0.03
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+1.25%
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+10.55%
/
-25.00%

NeoGenomics, Inc. earnings per share and revenue

On 28 de out. de 2025, NEO reported earnings of 0.03 USD per share (EPS) for Q3 25, beating the estimate of 0.02 USD, resulting in a 40.85% surprise. Revenue reached 187.80 milhão, compared to an expected 185.61 milhão, with a 1.18% difference. The market reacted with a -2.36% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analistas forecast an EPS of 0.03 USD, with revenue projected to reach 190.14 milhão USD, implying an aumentar of 0.00% EPS, and aumentar of 1.25% in Revenue from the last quarter.
FAQ
For Q3 2025, NeoGenomics, Inc. reported EPS of $0.03, beating estimates by 40.85%, and revenue of $187.80M, 1.18% above expectations.
The stock price moved down -2.36%, changed from $10.16 before the earnings release to $9.92 the day after.
The next earning report is scheduled for 16 de fev. de 2026.
Based on 15 analistas, NeoGenomics, Inc. is expected to report EPS of $0.03 and revenue of $190.14M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio